| Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients (NCT05181046) | Nanodropper, Inc. | 2021-11-06 |
| The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA (NCT05474716) | Fayoum University | 2020-05-01 |
| Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert (NCT04465864) | Wolstan and Goldberg Eye Associates | 2020-02-10 |
| Safety and IOP-Lowering Effects of WB007 (NCT04149899) | Bausch & Lomb Incorporated | 2019-11-14 |
| Caffeine Consumption in Glaucoma Patients and Healthy Subjects (NCT03675412) | Wills Eye | 2018-12-30 |
| UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma (NCT04321122) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2018-08-12 |
| Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution) (NCT04737928) | Santen Pharmaceutical (Taiwan) Co., LTD | 2018-04-02 |
| Adaptive Optics Retinal Imaging (NCT05370287) | Food and Drug Administration (FDA) | 2018-01-22 |
| Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily (NCT03067415) | Chong Kun Dang Pharmaceutical | 2017-03-30 |
| LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma (NCT03318510) | Augenabteilung Allgemeines Krankenhaus Linz | 2017-01-01 |
| Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension (NCT02858284) | EyeSonix | 2016-07-01 |
| Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT02796560) | Université de Sherbrooke | 2016-07-01 |
| Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent (NCT03151577) | Swiss Vision Network | 2015-01-01 |
| Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma (NCT02679482) | Fundación Oftalmológica Nacional | 2014-09-01 |
| A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting (NCT01999348) | Allergan | 2013-11-25 |
| A Study of Bimatoprost 0.01% in the Clinical Setting (NCT01814761) | Allergan | 2013-05-01 |
| A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons (NCT01853085) | Allergan | 2013-04-01 |
| NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement (NCT01408472) | Jeffrey L Goldberg | 2011-04-01 |
| Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01737853) | Allergan S.A. DE C.V.. | 2011-02-01 |
| Assessment of Effectiveness Ex-Press Surgery Modification (NCT03800589) | Military Institute od Medicine National Research Institute | 2010-12-01 |
| A Study of LUMIGAN® RC in the Clinical Setting (NCT01833741) | Allergan | 2009-12-01 |